BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30938189)

  • 1. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acrodermatitis continua of Hallopeau response to optimized biological therapy.
    Adas A; Dadban A; Arnault JP; Chaby G; Lok C
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
    Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
    Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
    Cirone KD; Lovegrove FE
    SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
    Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
    J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet.
    Pearson LH; Allen BS; Smith JG
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
    Iijima S; Okazaki Y; Watanabe S; Maruyama Y
    J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrodermatitis continua of hallopeau successfully treated with adalimumab.
    Sopkovich JA; Anetakis Poulos G; Wong HK
    J Clin Aesthet Dermatol; 2012 Feb; 5(2):60-2. PubMed ID: 22468174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized pustular psoriasis: a review and update on treatment.
    Hoegler KM; John AM; Handler MZ; Schwartz RA
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1645-1651. PubMed ID: 29573491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patients.
    Kromer C; Loewe E; Schaarschmidt ML; Pinter A; Gerdes S; Celis D; Poortinga S; Wilsmann-Theis D; Mössner R
    J Dermatol; 2020 Sep; 47(9):989-997. PubMed ID: 32632983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments.
    Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D
    Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
    Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.
    Sotiriadis D; Patsatsi A; Sotiriou E; Sotiriou E; Papagaryfallou I; Chrysomallis F
    J Dermatolog Treat; 2007; 18(5):315-8. PubMed ID: 17852633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
    Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
    Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.
    Chularojanamontri L; Silpa-Archa N; Pattamadilok B; Julanon N; Chuamanochan M; Pongcharoen P; Lertphanichkul C; Asawanonda P
    Exp Dermatol; 2024 Mar; 33(3):e15055. PubMed ID: 38519437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acrodermatitis continua of Hallopeau with ustekinumab as monotherapy after failure of anti-TNF agents.
    Palacios-Álvarez I; Simal-Gómez G; Mas-Vidal A; Bernad-Alonso I
    J Dtsch Dermatol Ges; 2018 May; 16(5):611-613. PubMed ID: 29659137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.